Apontis Pharma Overview
- Year Founded
-
1946
- Status
-
Acquired/Merged
- Employees
-
94
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
4
Apontis Pharma General Information
Description
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.
Contact Information
Website
www.apontis-pharma.de(Operating Subsidiary)
Corporate Office
- Rolf-Schwarz-Schütte-Platz 1
- 40789 Monheim am Rhein
- Germany
Corporate Office
- Rolf-Schwarz-Schütte-Platz 1
- 40789 Monheim am Rhein
- Germany
Apontis Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Apontis Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Apontis Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Apontis Pharma FAQs
-
When was Apontis Pharma founded?
Apontis Pharma was founded in 1946.
-
Where is Apontis Pharma headquartered?
Apontis Pharma is headquartered in Monheim am Rhein, Germany.
-
What is the size of Apontis Pharma?
Apontis Pharma has 94 total employees.
-
What industry is Apontis Pharma in?
Apontis Pharma’s primary industry is Pharmaceuticals.
-
Is Apontis Pharma a private or public company?
Apontis Pharma is a Private company.
-
What is the current valuation of Apontis Pharma?
The current valuation of Apontis Pharma is .
-
What is Apontis Pharma’s current revenue?
The current revenue for Apontis Pharma is .
-
How much funding has Apontis Pharma raised over time?
Apontis Pharma has raised $105M.
-
Who are Apontis Pharma’s investors?
Paragon Partners and UCB Pharma have invested in Apontis Pharma.
-
When was Apontis Pharma acquired?
Apontis Pharma was acquired on 13-Jun-2025.
-
Who acquired Apontis Pharma?
Apontis Pharma was acquired by Zentiva Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
